3/3 - A Neurobehavioral Family Study of Schizophrenia
3/3 - A Neurobehavioral Family Study of Schizophrenia
批准号:
8039333
负责人:
Laura A. Almasy
金额:
$2.77万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2011-02-28
关键词:
AdolescenceAgeAnatomyAnimal ExperimentationArchivesBehavioralBiological AssayBrainBrain DiseasesBrain regionCandidate Disease GeneCell LineCellsClinicalCodeCognitionCognitiveCommunitiesComplexDNADataData CollectionDatabasesDetectionDevelopmentDiagnosisDiagnosticDiffusion Magnetic Resonance ImagingEarly DiagnosisEmotionsEnvironmentEquilibriumEvaluationFailureFamilyFamily StudyFamily memberFunctional Magnetic Resonance ImagingFunctional RNAGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenotypeGoalsGuidelinesHeritabilityHumanIn VitroIndividualInvestigationLocationMagnetic Resonance ImagingMeasuresMethodsModelingNational Institute of Mental HealthNeuroanatomyNeurobiologyNeurocognitiveNeuronsNucleotidesOutcomeParticipantPathogenesisPerformancePhenotypePhysiologicalPhysiologyPredispositionProcessQuality ControlQuantitative GeneticsQuantitative Trait LociRegulationRelative (related person)ResourcesRiskSamplingSchizophreniaSignal TransductionSourceSpecimenSpeedStructureSymptomsSystemUpdateVariantbasebrain volumeclinical phenotypecomputerizedemerging adultfollow-upgenetic analysisgenetic linkage analysisgenetic pedigreegenetic variantgenome wide association studygenome-wide linkagehigh riskimprovedindexingmembermorphometryneurobehavioralneuroimagingneurophysiologypopulation basedpublic health relevancerelating to nervous systemrepositoryresponsesextrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neurobehavioral Family Study of Schizophrenia is a Multiplex Multigenerational Investigation (MGI) of three collaborative RO1s that combine genetic and neurobiologic paradigms to advance the understanding of pathogenesis and detection of genes that modulate susceptibility to schizophrenia (SCZ). Complex genetic mechanisms underlie the susceptibility to SCZ. Paralleling the progress in genetics, neurobiologic studies have identified neural systems that could provide pathophysiologic substrates for focused investigations. We have established a sample of multigenerational multiplex families that were ascertained, phenotypically characterized and genotyped for genome-wide linkage analyses. This sample was examined with a computerized neurocognitive battery that provides complementary quantitative phenotypes to diagnosis. We observed significant heritability for several neurocognitive domains as well as evidence for linkage. Our goal for the renewal application is to capitalize on this unique sample and obtain neuroimaging phenotypes of brain structure and function with Magnetic Resonance Imaging (MRI). We will examine brain structure using volume-based morphometry and connectivity with Diffusion Tensor Imaging (DTI). Functional MRI (fMRI) studies will examine brain circuitry activated in response to neurobehavioral probes. We will follow 300 individuals from the MGI sample for neuroimaging studies. We will also ascertain a new population-based sample of 300 community controls (Specific Aim 1). We will relate the heritability of neuroimaging phenotypes to symptom and neurobehavioral measures and perform multivariate quantitative genetic analyses to identify quantitative phenotypes influenced by the same genes (Specific Aim 2). To establish genetic mechanisms producing the neurobehavioral and neuroimaging phenotypes we will localize new quantitative trait loci through genome-wide association (GWA) analyses and follow-up significant linkage and GWA analysis signals as well as candidate genes identified through ongoing association studies (Specific Aim 3). Specimens will be sent to the NIMH repository for transformation and DNA extraction. Data collection and quality control will be maintained and verified data will be regularly uploaded to the NIMH repository (Specific Aim 4). The MGI augments other samples available with similar measures to confirm and extend present findings. In addition, the phenotypic characterization of participants with neurobehavioral and neuroimaging data will enable evaluation of the relation between genetic influences on neurobiological abnormalities and clinical manifestations. Finding additional potential quantitative markers for genetic vulnerability could improve our understanding of how genes related to brain development and regulation interact with environment in conferring SCZ susceptibility. Such efforts will enhance the integration of neurobiologic and genetic paradigms in human and animal research. In turn, this may pave the way for risk prediction and better treatment. PUBLIC HEALTH RELEVANCE: Schizophrenia is a complex brain disorder that commonly emerges in adolescence and early adulthood and has devastating effects on the individual and family. Understanding the genetic basis of the deficits in brain function is key to early detection and to advance treatments that may improve outcome. The goal of the Multiplex Multigenerational Investigation of the schizophrenia consortium is to integrate neurobehavioral and neuroimaging methods in high-risk families that will yield the data needed for progress in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Architecture of Early-Onset Psychosis in Mexicans (EPIMex)
-
批准号:10716496
-
项目类别:
-
资助金额:$244.67万
-
财政年份:2023
-
负责人:Laura A. Almasy
-
依托单位:
Genetic Architecture of Early-Onset Psychosis in Mexicans
-
批准号:10264286
-
项目类别:
-
资助金额:$289.98万
-
财政年份:2021
-
负责人:Laura A. Almasy
-
依托单位:
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:10085103
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:10610393
-
项目类别:
-
资助金额:$116.98万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:9926318
-
项目类别:
-
资助金额:$99.14万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Admin Supplement: Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:10660338
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:10380834
-
项目类别:
-
资助金额:$116.98万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability
-
批准号:9760145
-
项目类别:
-
资助金额:$104.61万
-
财政年份:2019
-
负责人:Laura A. Almasy
-
依托单位:
Genetic Analysis of Common Diseases: An Evaluation
-
批准号:9494763
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2017
-
负责人:Laura A. Almasy
-
依托单位:
Neurodevelopment: Genes, Environment, and their Interactions
-
批准号:9264864
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2015
-
负责人:Laura A. Almasy
-
依托单位:
Symposium on Advances in Genomics, Epidemiology, and Statistics (SAGES)
-
批准号:9919016
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2015
-
负责人:Laura A. Almasy
-
依托单位:
Neurodevelopment: Genes, Environment, and their Interactions
-
批准号:9271089
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2015
-
负责人:Laura A. Almasy
-
依托单位:
1/5 - Genetics of Transcriptional Endophenotypes for Schizophrenia
-
批准号:8657484
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2012
-
负责人:Laura A. Almasy
-
依托单位:
Characterization of a Mendelian Form of Psychosis in a Population Isolate
-
批准号:8494843
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2012
-
负责人:Laura A. Almasy
-
依托单位:
Characterization of a Mendelian Form of Psychosis in a Population Isolate
-
批准号:8547100
-
项目类别:
-
资助金额:$58.15万
-
财政年份:2012
-
负责人:Laura A. Almasy
-
依托单位:
1/5 - Genetics of Transcriptional Endophenotypes for Schizophrenia
-
批准号:8459923
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2012
-
负责人:Laura A. Almasy
-
依托单位:
1/5 - Genetics of Transcriptional Endophenotypes for Schizophrenia
-
批准号:8239315
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2012
-
负责人:Laura A. Almasy
-
依托单位:
GENETIC ANALYSIS OF CVD RISK FACTORS
-
批准号:8147522
-
项目类别:
-
资助金额:$49.3万
-
财政年份:2010
-
负责人:Laura A. Almasy
-
依托单位:
Genetic Analysis of CVD Risk Factors
-
批准号:7470224
-
项目类别:
-
资助金额:$46.49万
-
财政年份:2008
-
负责人:Laura A. Almasy
-
依托单位:
Genetic Variation in Factor IX and Thrombosis Risk
-
批准号:7414636
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2003
-
负责人:Laura A. Almasy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: